Abiopharma

Change - Change in Corporate Information: Change of Address of Registered Office and Principal Share Registrar in Bermuda

OwlTing Group (NASDAQ: OWLS) Reports OwlPay Harbor July Payment Volume Increased 107.6% Month Over Month

Avista Corp. Reports Q2 2026 Financial Results, Confirms 2026 Utility Earnings Guidance

Veritasium Goes Behind the Scenes at Kraig Biocraft Laboratories to Explore the Future of Commercial Spider Silk

REGENXBIO to Host Conference Call on August 6 to Discuss Second Quarter 2026 Financial Results and Operational Highlights

Publication date of financial statements as of 30.6.26 on 10.8.26, conference call on 13.8.26 at 9:30

General Announcement: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2026

Tonix Pharmaceuticals Announces Positive Minutes from Type C FDA Meeting to Discuss Adaptive Phase 2 Field Study of TNX-4800, a Human, anti-OspA Monoclonal Antibody, to Prevent Lyme Disease in the U.S.

X-energy, SGL Carbon Announce Capacity Expansion for Nuclear-Grade Graphite

Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome